Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-02-07 00:00:00 ET · period of report 2024-02-05 · accession 0001396814-24-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | 2024-02-05 | PCRX | GAUGLER DARYL | COO | A - Grant | $0.00 | +33.7K | 65.5K | +106% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-05 | A | A | 33,700 | $0.00 | 65,493.58 | D | — | — | (F1) Represents restricted stock units that vest on February 1, 2026, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. (F2) Includes 135.988 shares of common stock acquired under the issuer's employee stock purchase plan in December 2023. |